基本信息
views: 4
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
esearch in the Ernest and Helen Scott Haematological Research Institute focusses on the assessment and development of new targeted therapies for lymphoid malignancies.
A major strength of the group is the functional studies carried out on primary malignant cells. The group also has access to a unique collection of derived cell lines (and continue to generate new cell lines of biological interest) as well as generating unique patient-derived xenograft (PDX) models for which no cell lines currently exist, along with an extensive tissue bank of stored cells from patients with haematological malignancies. These models, combined with their ability to perform reverse translational studies in patients on clinical trials allows unique insights into tumour biology.
Research Interests
Papers共 557 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Nahide Yildirim, Lakshmi Sarojam,Victoria M. Smith, Nadja M. Pieper, Marius Anders,Ross A. Jackson,Dominik C. Fuhrmann,Vinzenz Saerchen, Daniela Bruecher,Andreas Weigert,Martin J. S. Dyer,Meike Vogler
William Townsend, Wolfgang Hiddemann,Christian Buske, Guillaume Cartron,David Cunningham,Martin J S Dyer,John G Gribben,Elizabeth H Phillips, Martin Dreyling,John F Seymour,Andrew Grigg,Judith Trotman,
HemaSphereno. 7 (2023): e919-e919
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
Blood advancesno. 14 (2023): 3378-3381
crossref(2023)
crossref(2023)
crossref(2023)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn